Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies

Glutamate neurotoxicity and diseases of the nervous system

Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,152 · see citing works

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works

Microglia: a sensor for pathological events in the CNS

Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · see citing works

Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease

(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · see citing works

Interactions Between the Microbiota and the Immune System

Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · see citing works

Host microbiota constantly control maturation and function of microglia in the CNS

Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569 · see citing works

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · see citing works

<i>TREM2</i> Variants in Alzheimer's Disease

Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · see citing works

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990 · see citing works

Variant of <i>TREM2</i> Associated with the Risk of Alzheimer's Disease

Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · see citing works

Immune attack: the role of inflammation in Alzheimer disease

Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134 · see citing works

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997 · see citing works

Gut microbiota are related to Parkinson's disease and clinical phenotype

Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968 · see citing works

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

Naj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901 · see citing works

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · see citing works

Innate immune activation in neurodegenerative disease

Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437 · see citing works

Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease

Seshadri, S. (2010) · JAMA · doi:10.1001/jama.2010.574 · Cited by 1,219 · see citing works

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200 · see citing works

Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease

Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172 · see citing works

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167 · see citing works

Systemic inflammation and disease progression in Alzheimer disease

Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bb95 · Cited by 1,139 · see citing works

Risk of Alzheimer's disease and duration of NSAID use

Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J. (1997) · Neurology · doi:10.1212/wnl.48.3.626 · Cited by 1,132 · see citing works

Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention

Tansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045 · see citing works

Peripheral education of the immune system by colonic commensal microbiota

Lathrop, S. K., Bloom, S. M., Rao, S. M., Nutsch, K., Lio, C.-W., Santacruz, N., Peterson, D. A., Stappenbeck, T. S., & Hsieh, C.-S. (2011) · Nature · doi:10.1038/nature10434 · Cited by 1,034 · see citing works

Systemic infections and inflammation affect chronic neurodegeneration

Perry, V. H., Cunningham, C., & Holmes, C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2015 · Cited by 1,027 · see citing works

Functional plasticity of microglia: A review

Streit, W. J., Graeber, M. B., & Kreutzberg, G. W. (1988) · Glia · doi:10.1002/glia.440010502 · Cited by 937 · see citing works

ApoE Promotes the Proteolytic Degradation of Aβ

Jiang, Q., Lee, C. Y. D., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T. M., Collins, J. L., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.010 · Cited by 876 · see citing works

Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients

Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90508-8 · Cited by 855 · see citing works

Microglial activation and dopamine terminal loss in early Parkinson's disease

Ouchi, Y., Yoshikawa, E., Sekine, Y., Futatsubashi, M., Kanno, T., Ogusu, T., & Torizuka, T. (2005) · Annals of Neurology · doi:10.1002/ana.20338 · Cited by 846 · see citing works

A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines

Rubio-Perez, J. M., & Morillas-Ruiz, J. M. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/756357 · Cited by 841 · see citing works

Microglia: Scapegoat, saboteur, or something else?

Aguzzi, A., Barres, B. A., & Bennett, M. L. (2013) · Science · doi:10.1126/science.1227901 · Cited by 836 · see citing works

Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients

Blum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12192-7 · Cited by 801 · see citing works

Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains

Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791 · see citing works

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease

Hamza, T. H., Zabetian, C. P., Tenesa, A., Laederach, A., Montimurro, J. S., Yearout, D., Kay, D. M., Doheny, K. F., Paschall, J. E., Pugh, E., et al. (2010) · Nature Genetics · doi:10.1038/ng.642 · Cited by 779 · see citing works

Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression

Griffin, W., Sheng, J. G., Royston, M., Gentleman, S., McKenzie, J., Graham, D. I., Roberts, G., & Mrak, R. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00136.x · Cited by 751 · see citing works

Microglia: biology and pathology

Graeber, M., & Streit, W. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0622-0 · Cited by 729 · see citing works

Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease

Streit, W. J., Braak, H., Xue, Q.-S., & Bechmann, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0556-6 · Cited by 727 · see citing works

Dystrophic microglia in the aging human brain

Streit, W. J., Sammons, N. W., Kuhns, A. J., & Sparks, D. L. (2004) · Glia · doi:10.1002/glia.10319 · Cited by 705 · see citing works

Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson disease

Hunot, S., Brugg, B., Ricard, D., Michel, P. P., Muriel, M., Ruberg, M., Faucheux, B. A., Agid, Y., & Hirsch, É. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7531 · Cited by 678 · see citing works

Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease

Chen, H., Zhang, S. M., Hernán, M. Á., Schwarzschild, M. A., Willett, W. C., Colditz, G. A., Speizer, F. E., & Ascherio, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1059 · Cited by 630 · see citing works

Inflammation and neurodegeneration in Parkinson's disease

McGeer, P. L., & McGeer, E. G. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.01.005 · Cited by 628 · see citing works

Inflammation as a causative factor in the aetiology of Parkinson's disease

Whitton, P. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707167 · Cited by 625 · see citing works

Changing face of microglia

Graeber, M. B. (2010) · Science · doi:10.1126/science.1190929 · Cited by 608 · see citing works

Neuroinflammation in Parkinson's disease

Hirsch, E. C., Vyas, S., & Hunot, S. (2012) · Parkinsonism &amp; Related Disorders · doi:10.1016/s1353-8020(11)70065-7 · Cited by 586 · see citing works

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides

Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1058 · Cited by 571 · see citing works

A High-Density Whole-Genome Association Study Reveals That APOE Is the Major Susceptibility Gene for Sporadic Late-Onset Alzheimer's Disease

Coon, K. D., Myers, A. J., Craig, D. W., Webster, J. A., Pearson, J. V., Lince, D. H., Zismann, V. L., Beach, T. G., Leung, D., Bryden, L., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0419 · Cited by 569 · see citing works

Peripheral cytokines profile in parkinson’s disease

Reale, M., Iarlori, C., Thomas, A., Gambi, D., Perfetti, B., Di Nicola, M., & Onofrj, M. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.07.003 · Cited by 547 · see citing works

Protective effects of NSAIDs on the development of Alzheimer disease

Vlad, S. C., Miller, D. R., Kowall, N. W., & Felson, D. T. (2008) · Neurology · doi:10.1212/01.wnl.0000311269.57716.63 · Cited by 535 · see citing works

Changes in cytokines and neurotrophins in Parkinson’s disease

Nagatsu, T., Mogi, M., Ichinose, H., & Togari, A. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_19 · Cited by 507 · see citing works

Role of microglia and host prion protein in neurotoxicity of a prion protein fragment

Brown, D. R., Schmidt, B., & Kretzschmar, H. A. (1996) · Nature · doi:10.1038/380345a0 · Cited by 499 · see citing works

Inflammation, autotoxicity and Alzheimer disease

McGeer, P. L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00289-5 · Cited by 474 · see citing works

Alzheimer’s Disease Genetics: From the Bench to the Clinic

Karch, C. M., Cruchaga, C., & Goate, A. M. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.041 · Cited by 473 · see citing works

The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy

McGeer, P. L., & McGeer, E. G. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1177-7 · Cited by 467 · see citing works

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs

Breitner, J. C. S. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00049-k · Cited by 466 · see citing works

Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease

Stein, P. S., Steffen, M. J., Smith, C. D., Jicha, G. A., Ebersole, J. L., Abner, E. L., & Dawson, D. R. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.04.006 · Cited by 463 · see citing works

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease

Cruchaga, C., Karch, C. M., Jin, S. C., Benitez, B. A., Cai, Y., Guerreiro, R., Harari, O., Norton, J., Budde, J., Bertelsen, S., et al. (2014) · Nature · doi:10.1038/nature12825 · Cited by 461 · see citing works

The Role of Glial Reaction and Inflammation in Parkinson's Disease

Hirsch, É. C., Breidert, T., Rousselet, E., Hunot, S., Hartmann, A., & Michel, P. P. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07478.x · Cited by 449 · see citing works

Anti-inflammatory drugs and Alzheimer disease

McGeer, P. L., McGeer, E. G., Rogers, J., & Sibley, J. T. (1990) · The Lancet · doi:10.1016/0140-6736(90)91101-f · Cited by 437 · see citing works

Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes

Jun, G. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.201 · Cited by 422 · see citing works

Inflammatory Process in Parkinsons Disease: Role for Cytokines

Nagatsu, T., & Sawada, M. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053381620 · Cited by 412 · see citing works

Inflammation and Alzheimer’s disease

Lee, Y.-J., Han, S. B., Nam, S.-Y., Oh, K.-W., & Hong, J. T. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-1006-7 · Cited by 396 · see citing works

Role of microglia in CNS inflammation

Graeber, M. B., Li, W., & Rodriguez, M. L. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.033 · Cited by 392 · cited 1× · see citing works

Long-term cerebral consequences of sepsis

Widmann, C. N., & Heneka, M. T. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70017-1 · Cited by 361 · see citing works

Glial cells and inflammation in parkinson's disease: A role in neurodegeneration?

Hirsch, É. C., Hunot, S., Damier, P., & Faucheux, B. A. (1998) · Annals of Neurology · doi:10.1002/ana.410440717 · Cited by 334 · see citing works

Role of cytokines in inflammatory process in Parkinson’s disease

Sawada, M., Imamura, K., & Nagatsu, T. (2006) · Parkinson’s Disease and Related Disorders · doi:10.1007/978-3-211-45295-0_57 · Cited by 331 · see citing works

CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease

Hutter-Saunders, J. A. L., Estes, K. A., Kosloski, L. M., Allen, H. E., Dempsey, K., Torres‐Russotto, D. R., Meza, J. L., Santamaria, P. M., Bertoni, J. M., Murman, D. L., et al. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9402-z · Cited by 325 · see citing works

The Role of Innate and Adaptive Immunity in Parkinson's Disease

Kannarkat, G. T., Boss, J. M., & Tansey, M. G. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130250 · Cited by 324 · see citing works

Peripheral Inflammatory Biomarkers and Risk of Parkinson's Disease

Chen, H., O'Reilly, E. J., Schwarzschild, M. A., & Ascherio, A. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm260 · Cited by 317 · see citing works

Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFα, and INFγ concentrations are elevated in patients with atypical and idiopathic parkinsonism

Brodacki, B., Staszewski, J., Toczyłowska, B., Kozłowska, E., Drela, N., Chalimoniuk, M., & Stępien, A. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.040 · Cited by 316 · see citing works

Reduced incidence of AD with NSAID but not H2receptor antagonists

Zandi, P. P., Anthony, J. C., Hayden, K. M., Mehta, K. M., Mayer, L. S., & Breitner, J. C. S. (2002) · Neurology · doi:10.1212/wnl.59.6.880 · Cited by 314 · see citing works

Coding variants in TREM2 increase risk for Alzheimer's disease

Jin, S. C., Benitez, B. A., Karch, C. M., Cooper, B., Skorupa, T., Carrell, D., Norton, J. B., Hsu, S., Harari, O., Cai, Y., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu277 · Cited by 314 · see citing works

The influence of microglia on the pathogenesis of Parkinson's disease

Long-Smith, C. M., Sullivan, A. M., & Nolan, Y. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.08.001 · Cited by 296 · see citing works

Microglia actions in Alzheimer's disease

Prokop, S., Miller, K. R., & Heppner, F. L. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1182-x · Cited by 291 · see citing works

Viral parkinsonism

Jang, H., Boltz, D. A., Webster, R. G., & Smeyne, R. J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.08.001 · Cited by 289 · see citing works

A study on the association between infectious burden and A lzheimer's disease

Bu, X., Yao, X., Jiao, S. ‐., Zeng, F., Liu, Y. ‐., Xiang, Y., Liang, C. ‐., Wang, Q. ‐., Wang, X., Cao, H., et al. (2014) · European Journal of Neurology · doi:10.1111/ene.12477 · Cited by 273 · see citing works

Periodontal disease associates with higher brain amyloid load in normal elderly

Kamer, A. R., Pirraglia, E., Tsui, W., Rusinek, H., Vallabhajosula, S., Mosconi, L., Li, Y., McHugh, P. F., Craig, R. G., Svetcov, S., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.038 · Cited by 270 · see citing works

Neurodegeneration and Inflammation in Parkinson's disease

Phani, S., Loike, J. D., & Przedborski, S. (2012) · Parkinsonism &amp; Related Disorders · doi:10.1016/s1353-8020(11)70064-5 · Cited by 263 · see citing works

CD33 Alzheimer’s risk-altering polymorphism, CD33 expression, and exon 2 splicing

Malik, M., Simpson, J. F., Parikh, I., Wilfred, B. R., Fardo, D. W., Nelson, P. T., & Estus, S. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1224-13.2013 · Cited by 262 · see citing works

Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer’s Disease

Eikelenboom, P., van Exel, E. R., Hoozemans, J. J. M., Veerhuis, R., Rozemüller, A. J. M., & van Gool, W. A. (2010) · Neurodegenerative Diseases · doi:10.1159/000283480 · Cited by 259 · see citing works

Microglia and neuroprotection: implications for Alzheimer's disease

Streit, W. J. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.013 · Cited by 256 · see citing works

Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys

Judith Miklossy, A., Doudet, D., Schwab, C., Yu, S. Y., McGeer, E. G., & McGeer, P. L. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.034 · Cited by 255 · see citing works

TREM2and Neurodegenerative Disease

Reitz, C., & Mayeux, R. P. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1306509 · Cited by 254 · see citing works

1918 INFLUENZA, ENCEPHALITIS LETHARGICA, PARKINSONISM

Ravenholt, R. T., & Foege, W. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90820-0 · Cited by 248 · see citing works

Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging

Mackenzie, I. R. A., & Munoz, D. G. (1998) · Neurology · doi:10.1212/wnl.50.4.986 · Cited by 244 · see citing works

Proinflammatory cytokines, sickness behavior, and Alzheimer disease

Holmes, C., Cunningham, C. M., Zotova, E., Culliford, D. J., & Perry, V. H. (2011) · Neurology · doi:10.1212/wnl.0b013e318225ae07 · Cited by 242 · see citing works

Role of microglia in neuronal cell death in prion disease

Giese, A., Brown, D. R., Groschup, M. H., Feldmann, C., Haist, I., & Kretzschmar, H. A. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00167.x · Cited by 239 · see citing works

The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease

Dursun, E., Gezen-Ak, D., Hanağası, H., Bilgiç, B., Lohmann, E., Ertan, S., Atasoy, İ. L., Alaylıoğlu, M., Araz, Ö. S., Önal, B., et al. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.04.014 · Cited by 237 · see citing works

Inflammatory Aspects of Alzheimer Disease and Other Neurodegenerative Disorders

Schwab, C., & McGeer, P. L. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13402 · Cited by 234 · see citing works

Imaging Approaches to Parkinson Disease

Brooks, D. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.059998 · Cited by 234 · see citing works

Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites

Brouwers, N., Van Cauwenberghe, C., Engelborghs, S., Lambert, J.-C., Bettens, K., Le Bastard, N., Pasquier, F., Montoya, A. G., Peeters, K., Mattheijssens, M., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.24 · Cited by 227 · see citing works

Increased Serum IL-1β Level in Alzheimer’s Disease and Mild Cognitive Impairment

Forlenza, O. V., Diniz, B. S., Talib, L. L., Mendonça, V. A., Ojopi, E. P. B., Gattaz, W. F., & Teixeira, A. L. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000255051 · Cited by 218 · see citing works

Neuroinflammation in the living brain of Parkinson's disease

Ouchi, Y., Yagi, S., Yokokura, M., & Sakamoto, M. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70814-4 · Cited by 210 · see citing works

Genetics of Alzheimer’s Disease

Chouraki, V. A., & Seshadri, S. S. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800149-3.00005-6 · Cited by 208 · see citing works

Herpes virus in Alzheimer's disease: relation to progression of the disease

Carbone, I., Lazzarotto, T., Ianni, M., Porcellini, E., Forti, P., Masliah, E., Gabrielli, L., & Licastro, F. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.024 · Cited by 208 · see citing works

Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease?

Honjo, K., van Reekum, R., & Verhoeff, N. P. L. G. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.12.001 · Cited by 204 · see citing works

Convergent genetic and expression data implicate immunity in Alzheimer's disease

International Genomics of Alzheimer's Disease Consortium (IGAP), Jones, L., Lambert, J., Wang, L., Choi, S., Harold, D., Vedernikov, A., Escott‐Price, V., Stone, T., Richards, A., et al. (2015) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2014.05.1757 · Cited by 199 · see citing works

Emerging roles of pathogens in Alzheimer disease

Miklossy, J. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002006 · Cited by 199 · see citing works

Inflammation in Parkinson's Disease

Tüfekçi, K. U., Meuwissen, R. L. J., Genç, Ş., & Genç, K. (2012) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-398314-5.00004-0 · Cited by 199 · see citing works

SORL1 Is Genetically Associated with Late-Onset Alzheimer’s Disease in Japanese, Koreans and Caucasians

Miyashita, A., Koike, A., Jun, G., Wang, L.-S., Takahashi, S., Matsubara, E., Kawarabayashi, T., Shoji, M., Tomita, N., Arai, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058618 · Cited by 196 · see citing works

Neuroinflammatory phenotype in early Alzheimer's disease

Sudduth, T. L., Schmitt, F. A., Nelson, P. T., & Wilcock, D. M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.09.012 · Cited by 194 · see citing works

Association of Parkinson Disease with Structural and Regulatory Variants in the HLA Region

Wissemann, W. T., Hill-Burns, E. M., Zabetian, C. P., Factor, S. A., Patsopoulos, N., Hoglund, B., Holcomb, C., Donahue, R. J., Thomson, G., Erlich, H., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.10.009 · Cited by 189 · see citing works

Reduced T helper and B lymphocytes in Parkinson's disease

Stevens, C. H., Rowe, D. B., Morel‐Kopp, M., Orr, C., Russell, T., Ranola, M., Wård, C., & Halliday, G. M. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.07.015 · Cited by 189 · see citing works

Biochemistry of postmortem brains in Parkinson’s disease: historical overview and future prospects

Nagatsu, T., & Sawada, M. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_14 · Cited by 185 · see citing works

Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease: A Genome-Wide Association Study

Naj, A. C., Jun, G., Reitz, C., Kunkle, B. W., Perry, W., Park, Y. S., Beecham, G. W., Rajbhandary, R. A., Hamilton-Nelson, K. L., Wang, L.-S., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1491 · Cited by 185 · see citing works

The Role of Inflammatory Cytokines in Cognition and Other Non-Motor Symptoms of Parkinson's Disease

Menza, M. A., Dobkin, R. D., Marín, H., Mark, M. H., Gara, M. A., Bienfait, K., Dicke, A., & Kusnekov, A. (2010) · Psychosomatics · doi:10.1016/s0033-3182(10)70739-8 · Cited by 182 · see citing works

Critical Role of Astroglial Apolipoprotein E and Liver X Receptor-α Expression for Microglial Aβ Phagocytosis

Terwel, D., Steffensen, K. R., Verghese, P. B., Kummer, M. P., Gustafsson, J.-Å., Holtzman, D. M., & Heneka, M. T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6546-10.2011 · Cited by 181 · see citing works

Cytomegalovirus Infection and Risk of Alzheimer Disease in Older Black and White Individuals

Barnes, L. L., Capuano, A. W., Aiello, A. E., Turner, A. D., Yolken, R. H., Torrey, Ε. F., & Bennett, D. A. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu437 · Cited by 178 · see citing works

A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity

Guo, L., LaDu, M. J., & Van Eldik, L. J. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:205 · Cited by 175 · see citing works

Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly

Sardi, F., Fassina, L., Venturini, L., Inguscio, M., Guerriero, F., Rolfo, E., & Ricevuti, G. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.09.005 · Cited by 171 · see citing works

Role of Phosphatidylinositol Clathrin Assembly Lymphoid-Myeloid Leukemia (PICALM) in Intracellular Amyloid Precursor Protein (APP) Processing and Amyloid Plaque Pathogenesis

Xiao, Q., Gil, S.-C., Yan, P., Wang, Y., Han, S., Gonzales, E., Perez, R., Cirrito, J. R., & Lee, J.-M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.338376 · Cited by 166 · see citing works

Unique inflammatory RNA profiles of microglia in Creutzfeldt–Jakob disease

Baker, C. A., & Manuelidis, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237313100 · Cited by 165 · see citing works

<i><scp>APOE</scp></i>‐modulated Aβ‐induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective

Tai, L. M., Ghura, S., Koster, K. P., Liakaite, V., Maienschein‐Cline, M., Kanabar, P., Collins, N., Ben‐Aissa, M., Lei, A. Z., Bahroos, N., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13072 · Cited by 165 · see citing works

Meta-analysis of the Association Between Variants in SORL1 and Alzheimer Disease

Reitz, C. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.346 · Cited by 162 · see citing works

NSAID Use and the Risk of Parkinsonʼs Disease

Samii, A., Etminan, M., Wiens, M. O., & Jafari, S. (2009) · Drugs & Aging · doi:10.2165/11316780-000000000-00000 · Cited by 161 · see citing works

Inflammatory markers in AD and MCI patients with different biomarker profiles

Schuitemaker, A., Dik, M. G., Veerhuis, R., Scheltens, P., Schoonenboom, N. S. M., Hack, C. E., Blankenstein, M. A., & Jonker, C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.014 · Cited by 149 · see citing works

The immunobiology of prion diseases

Aguzzi, A., Nuvolone, M., & Zhu, C. (2013) · Nature reviews. Immunology · doi:10.1038/nri3553 · Cited by 146 · see citing works

The probable relation between Toxoplasma gondii and Parkinson's disease

Miman, Ö., Küsbeci, Ö. Y., Aktepe, O. C., & Çetınkaya, Z. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.03.057 · Cited by 144 · see citing works

Inflammatory Cytokine Gene Polymorphisms and Increased Risk of Parkinson Disease

Wahner, A. D., Sinsheimer, J. S., Bronstein, J. M., & Ritz, B. R. (2007) · Archives of Neurology · doi:10.1001/archneur.64.6.836 · Cited by 143 · see citing works

Rheumatold Arthritis and Senile Dementia of the Alzhelmer's Type

Jenkinson, M. L., Bliss, M. R., BRAIN, A. T., & Scott, D. L. (1989) · Lara D. Veeken · doi:10.1093/rheumatology/28.1.86-b · Cited by 143 · see citing works

Herpes Simplex Virus Type 1 in Alzheimer's Disease: The Enemy Within

Itzhaki, R. F., & Wozniak, M. A. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13405 · Cited by 143 · see citing works

Inflammatory cytokines and NT-proCNP in Parkinson’s disease patients

Koziorowski, D., Tomasiuk, R., Szlufik, S., & Friedman, A. (2012) · Cytokine · doi:10.1016/j.cyto.2012.07.030 · Cited by 142 · see citing works

Peripheral Cytokines and Chemokines in Alzheimer’s Disease

Lee, K. S., Chung, J. H., Choi, T.-K., Suh, S. Y., Oh, B. H., & Hong, C. H. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000245156 · Cited by 140 · see citing works

A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease

Holmans, P., Moskvina, V., Jones, L., Sharma, M., Vedernikov, A., Büchel, F., Sadd, M., Brás, J., Bettella, F., Nicolaou, N., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds492 · Cited by 139 · see citing works

Herpes simplex infection and the risk of Alzheimer’s disease: A nested case-control study

Lövheim, H., Gilthorpe, J., Johansson, A., Eriksson, S., Hallmans, G., & Elgh, F. (2015) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2014.07.157 · Cited by 136 · see citing works

IL-1β, IL-2, IL-6 and TNF-α production by peripheral blood mononuclear cells from patients with Parkinson's disease

Bessler, H., Djaldetti, R., Salman, H., Bergman, M., & Djaldetti, M. (1999) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(99)80079-1 · Cited by 135 · see citing works

Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains

Imamura, K., Hishikawa, N., Ono, K., Suzuki, H., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0919-y · Cited by 131 · see citing works

Subsequent Risks of Parkinson Disease in Patients with Autoimmune and Related Disorders: A Nationwide Epidemiological Study from Sweden

Li, X., Sundquist, J., & Sundquist, K. (2011) · Neurodegenerative Diseases · doi:10.1159/000333222 · Cited by 129 · see citing works

Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles

Baker, C. A., Martin, D., & Manuelidis, L. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10905-10913.2002 · Cited by 128 · see citing works

Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease

Lio, D., Licastro, F., Scola, L., Chiappelli, M., Grimaldi, L. M. E., Crivello, A., Colonna‐Romano, G., Candore, G., Franceschi, C., & Caruso, C. (2003) · Genes and Immunity · doi:10.1038/sj.gene.6363964 · Cited by 127 · see citing works

Neuroinflammatory Signals in Alzheimer Disease and APP/PS1 Transgenic Mice

López‐González, I., Schlüter, A., Aso, E., Garcia‐Esparcia, P., Ansoleaga, B., Llorens, F., Carmona, M., Moreno, J. R., Fuso, A., Portero‐Otín, M., et al. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000176 · Cited by 125 · see citing works

Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis

Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · see citing works

The medial and lateral substantia nigra in Parkinson’s disease: mRNA profiles associated with higher brain tissue vulnerability

Duke, D. C., Moran, L. B., Pearce, R. K. B., & Graeber, M. B. (2007) · Neurogenetics · doi:10.1007/s10048-006-0077-6 · Cited by 121 · see citing works

Autoimmune disease and risk for Parkinson disease

Rugbjerg, K., Friis, S., Ritz, B. R., Schernhammer, E. S., Korbo, L., & Olsen, J. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c06635 · Cited by 120 · see citing works

Circulating interleukin-15 and RANTES chemokine in Parkinson’s disease

Rentzos, M., Nikolaou, C., Andreadou, E., Paraskevas, G. P., Rombos, A., Zoga, M., Tsoutsou, A., Boufidou, F., Kapaki, E., & Vassilopoulos, D. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00894.x · Cited by 119 · see citing works

Association of interleukin-1β polymorphisms with idiopathic Parkinson's disease

McGeer, P. L., Yasojima, K., & McGeer, E. G. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00300-2 · Cited by 118 · see citing works

Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson's disease

Scalzo, P. L., Kümmer, A., Cardoso, F., & Teixeira, A. L. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.08.001 · Cited by 118 · see citing works

Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia

Ruiz, A., Dols-Icardo, O., Bullido, M. J., Pastor, P., Rodríguez-Rodríguez, E., López de Munain, A., de Pancorbo, M. M., Pérez-Tur, J., Álvarez, V., Antonell, A., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.011 · Cited by 118 · see citing works

Upregulation of Micro RNA-146a (miRNA-146a), A Marker for Inflammatory Neurodegeneration, in Sporadic Creutzfeldt–Jakob Disease (sCJD) and Gerstmann–Straussler–Scheinker (GSS) Syndrome

Lukiw, W. J., Dua, P., Pogue, A. I., Eicken, C., & Hill, J. M. (2011) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2011.618973 · Cited by 116 · see citing works

The Role of Inflammatory Cytokines in Cognition and Other Non-Motor Symptoms of Parkinson's Disease

Menza, M., Dobkin, R. D., Marin, H., et al. (2010) · Psychosomatics · doi:10.1176/appi.psy.51.6.474 · Cited by 116 · see citing works

Neurotoxicity from innate immune response is greatest with targeted replacement of ε4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK

Maezawa, I., Nivison, M. P., Montine, K. S., Maeda, N., & Montine, T. J. (2006) · The FASEB Journal · doi:10.1096/fj.05-5423fje · Cited by 113 · see citing works

CD33 in Alzheimer's Disease

Jiang, T., Yu, J., Hu, N., Tan, M., Zhu, X., & Tan, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8536-1 · Cited by 106 · see citing works

Expression Profiles of Cytokines in the Brains of Alzheimer's Disease (AD) Patients Compared to the Brains of Non-Demented Patients with and without Increasing AD Pathology

Morimoto, K., Horio, J., Satoh, H., Sue, L. I., Beach, T. G., Arita, S., Tooyama, I., & Konishi, Y. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101815 · Cited by 105 · see citing works

Patterns of microglial cell activation in frontotemporal lobar degeneration

Lant, S. B., Robinson, A. C., Thompson, J. C., Rollinson, S., Pickering‐Brown, S., Snowden, J. S., Davidson, Y. S., Gerhard, A., & Mann, D. M. A. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12092 · Cited by 102 · see citing works

Apolipoprotein E gene in frontotemporal dementia: an association study and meta-analysis

Verpillat, P., Camuzat, A., Hannequin, D., Thomas-Antérion, C., Puel, M., Belliard, S., Dubois, B., Didic, M., Lacomblez, L., Moreaud, O., et al. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200820 · Cited by 100 · see citing works

Microglia and the pathogenesis of spongiform encephalopathies

Rezaie, P. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00042-x · Cited by 99 · see citing works

Serum inflammatory biomarkers in Parkinson's disease

Dufek, M., Hamanová, M., Lokaj, J., Goldemund, D., Rektorová, I., Michálková, Z., Sheardová, K., & Rektor, I. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.05.014 · Cited by 99 · see citing works

Circulating interleukin-10 and interleukin-12 in Parkinson’s disease

Rentzos, M., Nikolaou, C., Andreadou, E., Paraskevas, G. P., Rombos, A., Zoga, M., Tsoutsou, A., Boufidou, F., Kapaki, E., & Vassilopoulos, D. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01103.x · Cited by 99 · see citing works

Higher Serum sTNFR1 Level Predicts Conversion from Mild Cognitive Impairment to Alzheimer's Disease

Diniz, B. S., Teixeira, A. L., Ojopi, E. P. B., Talib, L. L., Mendonça, V. A., Gattaz, W. F., & Forlenza, O. V. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100921 · Cited by 99 · see citing works

Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer’s disease

Dorey, E., Chang, N., Liu, Q. Y., Yang, Z., & Zhang, W. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1422-z · Cited by 99 · see citing works

Chemokines and Alzheimer's disease

Streit, W. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00290-1 · Cited by 94 · see citing works

Genetic analysis of immunomodulating factors in sporadic Parkinson's disease

Krüger, R., Hardt, C., Tschentscher, F., Jäckel, S., Kuhn, W., Müller, T., Werner, J., Woitalla, D., Berg, D., Kühnl, N., et al. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070078 · Cited by 93 · see citing works

Cytokine expression and microglial activation in progressive supranuclear palsy

Fernández-Botrán, R., Ahmed, Z., Crespo, F. A., Gatenbee, C., Gonzalez, J., Dickson, D. W., & Litvan, I. (2011) · Parkinsonism &amp; Related Disorders · doi:10.1016/j.parkreldis.2011.06.007 · Cited by 93 · see citing works

Microglia and the Development of Spongiform Change in Creutzfeldt-Jakob Disease

Eitzen, U., Egensperger, R., Kösel, S., Grasbon-Frodl, E., Imai, Y., Bise, K., Kohsaka, S., Mehraein, P., & Graeber, M. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199803000-00006 · Cited by 92 · see citing works

Microglial Activation Varies in Different Models of Creutzfeldt-Jakob Disease

Baker, C. A., Lu, Z.-Y., Zaitsev, I., & Manuelidis, L. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.5089-5097.1999 · Cited by 91 · see citing works

Interleukin-2 but not basic fibroblast growth factor is elevated in parkinsonian brain

Mogi, M., Harada, M., Kondo, T., Riederer, P. F., & Nagatsu, T. (1996) · Journal of Neural Transmission · doi:10.1007/bf01291792 · Cited by 90 · see citing works

The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease

Ma, S. L., Tang, N. L. S., LAM, L. C. W., & Chiu, H. F. K. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.010 · Cited by 89 · see citing works

Presence of Reactive Microglia and Neuroinflammatory Mediators in a Case of Frontotemporal Dementia with P301S Mutation

Bellucci, A., Bugiani, O., Ghetti, B. F., & Spillantini, M. G. (2011) · Neurodegenerative Diseases · doi:10.1159/000322228 · Cited by 88 · see citing works

Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders

Schofield, E. C. (2003) · Brain · doi:10.1093/brain/awg085 · Cited by 86 · see citing works

The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease

Everbroeck, B. V., Dewulf, E. M., Pals, P., Lübke, U., Martin, J., & Cras, P. P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00236-6 · Cited by 85 · see citing works

CR1 in Alzheimer's Disease

Zhu, X., Yu, J., Jiang, T., Wang, P., Cao, L., & Tan, L. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8723-8 · Cited by 84 · see citing works

Interaction of polymorphisms in the genes encoding interleukin‐6 and estrogen receptor beta on the susceptibility to Parkinson's disease

Håkansson, A. S., Westberg, L., Nilsson, S., Buervenich, S., Belin, A. C., Holmberg, B., Sydow, O., Olson, L., Johnels, B., Eriksson, E., et al. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30136 · Cited by 83 · see citing works

Alzheimer's Disease and Rheumatoid Arthritis

Myllykangas-Luosujärvi, R., & Isomäki, H. A. (1994) · Lara D. Veeken · doi:10.1093/rheumatology/33.5.501 · Cited by 82 · see citing works

Association of an interleukin 1B gene polymorphism (−511) with Parkinson's disease in Finnish patients

Mattila, K. M., Rinne, J. O., Lehtimäki, T. J., Röyttä, M., Ahonen, J.-P., & Hurme, M. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.6.400 · Cited by 81 · see citing works

Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice

Maezawa, I., Maeda, N., Montine, T. J., & Montine, K. S. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-10 · Cited by 81 · see citing works

Complex Deregulation and Expression of Cytokines and Mediators of the Immune Response in P arkinson's Disease Brain is Region Dependent

Garcia‐Esparcia, P., Llorens, F., Carmona, M., & Ferrer, I. (2014) · Brain Pathology · doi:10.1111/bpa.12137 · Cited by 80 · see citing works

SORL1 variants and risk of late-onset Alzheimer’s disease

Li, Y., Rowland, C. M., Catanese, J. J., Morris, J. C., Lovestone, S., O’Donovan, M. C., Goate, A., Owen, M. J., Williams, J. H., & Grupe, A. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.09.001 · Cited by 79 · see citing works

Genetic risk profiles for Alzheimer's disease: Integration of APOE genotype and variants that up-regulate inflammation

Licastro, F., Porcellini, E., Caruso, C., Lio, D., & Corder, E. H. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.07.007 · Cited by 78 · see citing works

Genetics of Progressive Supranuclear Palsy

Im, S. Y., Kim, Y. E., & Kim, Y. J. (2015) · Journal of Movement Disorders · doi:10.14802/jmd.15033 · Cited by 76 · see citing works

Relationship of microglia and scrapie amyloid-immunoreactive plaques in kuru, Creutzfeldt-Jakob disease and Gerstmann-Str�u�ler syndrome

Guiroy, D. C., WAKAYAMA, I., Liberski, P. P., & Gajdusek, D. C. (1994) · Acta Neuropathologica · doi:10.1007/bf00294180 · Cited by 71 · see citing works

Macrophage-Mediated Degradation of β-Amyloid via an Apolipoprotein E Isoform-Dependent Mechanism

Zhao, L., Lin, S., Bales, K. R., Gelfanova, V., Koger, D., DeLong, C. A., Hale, J. E., Liu, F., Hunter, J. M., & Paul, S. M. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5302-08.2009 · Cited by 69 · see citing works

Subtype and Regional-Specific Neuroinflammation in Sporadic Creutzfeldt–Jakob Disease

Llorens, F., López-González, I., Thüne, K., Carmona, M., Zafar, S., Andréoletti, O., Zerr, I., & Ferrer, I. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00198 · Cited by 69 · see citing works

Association of the human leucocyte antigen region with susceptibility to Parkinson's disease

Saiki, M., Baker, A., Williams‐Gray, C. H., Foltynie, T., Goodman, R. S., Taylor, C. J., Compston, D. A. S., Barker, R., Sawcer, S. J., & Goris, A. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.162883 · Cited by 68 · see citing works

Evidence for More than One Parkinson's Disease-Associated Variant within the HLA Region

Hill‐Burns, E. M., Factor, S. A., Zabetian, C. P., Thomson, G. J., & Payami, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027109 · Cited by 66 · see citing works

The effects of APOE and tau gene variability on risk of frontotemporal dementia

Bernardi, L., Maletta, R., Tomaino, C., Smirne, N., Natale, M. D., Perri, M., Longo, T., Colao, R., Curcio, S. A. M., Puccio, G., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.008 · Cited by 64 · see citing works

Reactive microgIia in Creutzfeldt‐Jakob disease

Mühleisen, H., Gehrmann, J., & Meyermann, R. (1995) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1995.tb01097.x · Cited by 63 · see citing works

Infections as a risk factor for Parkinson's disease: a case–control study

Vlajinac, H., Dzoljic, E. D., Maksimovic, J. M., Marinković, J., Grujičić, S. Š., & Kostić, V. (2012) · International Journal of Neuroscience · doi:10.3109/00207454.2012.760560 · Cited by 59 · see citing works

Interleukin-10 (IL10) and tumor necrosis factor α (TNF) gene polymorphisms in Parkinson's disease patients

Białecka, M. A., Kłodowska-Duda, G. A., Kurzawski, M., Sławek, J. W., Gorzkowska, A., Opala, G., Białecki, P., Sagan, L. M., & Droździk, M. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.02.001 · Cited by 58 · see citing works

Effect of Proinflammatory Gene Polymorphisms on the Risk of Alzheimer's Disease

Flex, A., Giovannini, S., Biscetti, F., Liperoti, R., Spalletta, G., Straface, G., Landi, F., Angelini, F., Caltagirone, C., Ghirlanda, G., et al. (2013) · Neurodegenerative Diseases · doi:10.1159/000353395 · Cited by 57 · see citing works

History of Innate Immunity in Neurodegenerative Disorders

McGeer, P. L., & McGeer, E. G. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00077 · Cited by 52 · see citing works

Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease.

Hirsch, É. C., Hunot, S., Damier, P., Brugg, B., Faucheux, B. A., Michel, P. P., Ruberg, M., Muriel, M., Prigent, A., & Agid, Y. (1999) · PubMed · Cited by 52 · see citing works

Commentary on the letter for Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease?

Honjo, K., van Reekum, R., & Verhoeff, N. P. L. G. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.07.146 · Cited by 51 · see citing works

Association between apolipoprotein E polymorphism and Alzheimer's disease in Koreans

Kim, K. W., Jhoo, J. H., Lee, K. U., Lee, D. Y., Lee, J. H., Youn, J. Y., Lee, B. J., Han, S. H., & Woo, J. I. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00867-8 · Cited by 50 · see citing works

Polymorphisms in immune/inflammatory cytokine genes are related to Parkinson's disease with cognitive impairment in the Han Chinese population

Nie, K., Zhang, Y., Gan, R., Wang, L., Zhao, J., Huang, Z., Tang, H., & Wang, L. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.02.024 · Cited by 49 · see citing works

Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer's disease and multiple sclerosis

Stoeck, K., Schmitz, M., Ebert, E., Schmidt, C., & Zerr, I. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0170-y · Cited by 49 · see citing works

Heightened intrathecal release of proinflammatory cytokines in Creutzfeldt–Jakob disease

Sharief, M. K., Green, A. J. E., Dick, J. P. R., Gawler, J., & Thompson, E. J. (1999) · Neurology · doi:10.1212/wnl.52.6.1289 · Cited by 48 · see citing works

Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4.

Rao, V. S., Cupples, L. A., van Duijn, C. M., Kurz, A., Green, R. C., Chui, H. C., Duara, R., Auerbach, S. H., Volicer, L., Wells, J., et al. (1996) · PubMed Central · Cited by 47 · see citing works

Biomarkers of inflammation and amyloid-β phagocytosis in patients at risk of Alzheimer disease

Fiala, M., & Veerhuis, R. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.08.003 · Cited by 45 · see citing works

Go with your gut: microbiota meet microglia

Mosher, K. I., & Wyss‐Coray, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4051 · Cited by 44 · see citing works

Untitled work

(2012) · PubMed · Cited by 42 · see citing works

Microglial reaction in Pick's disease

Paulus, W., Bancher, C., & Jellinger, K. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90147-d · Cited by 42 · see citing works

Pro- and anti-inflammatory cytokines in the CSF of patients with creutzfeldt-jakob disease.

Stoeck, K., Bodemer, M., & Zerr, I. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.10.008 · Cited by 42 · see citing works

The association between promoter polymorphism of the interleukin-10 gene and Alzheimer＇s disease

Ma, Sl, Tang, Lam, 。., Lc, & Chiu (2006) · 中国生物学文摘 · Cited by 42 · see citing works

TREM2 Risk Variant and Loss of Brain Tissue

Rajagopalan, P., Hibar, D. P., & Thompson, P. M. (2013) · Europe PMC (PubMed Central) · doi:10.1056/nejmc1306509#sa3 · Cited by 41 · see citing works

Microglia activation mediates fibrillar amyloid-β toxicity in the aged primate cortex

Leung, E., Guo, L., Bu, J., Maloof, M. E., Khoury, J. B. E., & Geula, C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.025 · Cited by 40 · see citing works

The apolipoprotein E 4 allele selectively increases the risk of frontotemporal lobar degeneration in males

Srinivasan, R. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.063966 · Cited by 39 · see citing works

Sporadic Creutzfeldt-Jakob Disease: The Extent of Microglia Activation Is Dependent on the Biochemical Type of PrPSc

Puoti, G., Giaccone, G., Mangieri, M., Limido, L., Fociani, P., Zerbi, P., Suardi, S., Rossi, G., Iussich, S., Capobianco, R., et al. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000183346.19447.55 · Cited by 38 · see citing works

TREM2 variants and risk of Alzheimer’s disease: a meta-analysis

Lu, Y., Liu, W., & Wang, X. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2274-2 · Cited by 37 · see citing works

Brain microglia were activated in sporadic CJD but almost unchanged in fatal familial insomnia and G114V genetic CJD

Shi, Q., Xie, W.-L., Zhang, B., Chen, L., Xu, Y., Wang, K., Ren, K., Zhang, X.-M., Chen, C., Zhang, J., et al. (2013) · Virology Journal · doi:10.1186/1743-422x-10-216 · Cited by 37 · see citing works

Inflammation‐related genes and the risk of Parkinson’s disease: a multilocus approach

Infante, J., García‐Gorostiaga, I., Sánchez‐Juan, P., Sánchez‐Quintana, C., Martín-Gurpegui, J. L., Rodríguez‐Rodríguez, E., Mateo, I., Berciano, J., & Combarros, O. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02092.x · Cited by 34 · see citing works

Interleukin-18 promoter polymorphisms and risk of Parkinson's disease in a Han Chinese population

Xu, X., Li, D., He, Q. W., Gao, J., Chen, B., & Xie, A. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.025 · Cited by 34 · see citing works

Neuroinflammation as a common feature of neurodegenerative disorders

Guzman-Martinez, L., Maccioni, R. B., Andrade, V., Navarrete, L. P., Pastor, M. G., & Ramos-Escobar, N. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01008 · Cited by 702 · see citing works

Glial contributions to neurodegeneration in tauopathies

Leyns, C. E. G., & Holtzman, D. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0192-x · Cited by 409 · see citing works

Alzheimer’s Disease: An Update and Insights Into Pathophysiology

Abubakar, M. B., Sanusi, K. O., Ugusman, A., Mohamed, W. M. Y., Kamal, H., Ibrahim, N. H., Khoo, C. S., & Kumar, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.742408 · Cited by 293 · see citing works

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias

Llorens, F., Thüne, K., Tahir, W., Kanata, E., Diaz-Lucena, D., Xanthopoulos, K., Kovatsi, E., Pleschka, C., Garcia-Esparcia, P., Schmitz, M., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0226-4 · Cited by 249 · see citing works

The Role of Sex and Sex Hormones in Neurodegenerative Diseases

Vegeto, E., Villa, A. M., Torre, S. D., Crippa, V., Rusmini, P., Cristofani, R., Galbiati, M., Maggi, A. C., & Poletti, A. (2019) · Endocrine Reviews · doi:10.1210/endrev/bnz005 · Cited by 231 · see citing works

Microglia in Parkinson's disease

Ho, M. S. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-9913-8_13 · Cited by 227 · see citing works

Chronic intermittent hypoxia induces oxidative stress and inflammation in brain regions associated with early-stage neurodegeneration

Snyder, B., Shell, B., Cunningham, J. T., & Cunningham, R. L. (2017) · Physiological Reports · doi:10.14814/phy2.13258 · Cited by 190 · see citing works

Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy

Cuadrado, A., Kügler, S., & Lastres‐Becker, I. (2017) · Redox Biology · doi:10.1016/j.redox.2017.10.010 · Cited by 180 · see citing works

Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson’s Disease?

Janda, E., Boi, L., & Carta, A. R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00144 · Cited by 175 · see citing works

Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson’s disease

Li, Q., Wang, Z., Xing, H., Wang, Y., & Guo, Y. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.01.022 · Cited by 165 · see citing works

Prenatal Immune Challenge in Mice Leads to Partly Sex-Dependent Behavioral, Microglial, and Molecular Abnormalities Associated with Schizophrenia

Hui, C. W., St-Pierre, A., Hajj, H. E., Remy, Y., Hébert, S. S., Luheshi, G. N., Srivastava, L. K., & Tremblay, M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00013 · Cited by 158 · see citing works

Pharmacological Targeting of Microglial Activation: New Therapeutic Approach

Liu, C., Wang, X., Liu, C., & Zhang, H. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00514 · Cited by 141 · see citing works

A unifying hypothesis for Alzheimer's disease: from plaques to neurodegeneration

Edwards, F. A. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.03.003 · Cited by 140 · see citing works

Diversity of astroglial responses across human neurodegenerative disorders and brain aging

Ferrer, I. (2017) · Brain Pathology · doi:10.1111/bpa.12538 · Cited by 123 · see citing works

Sulforaphane attenuates microglia-mediated neuronal necroptosis through down-regulation of MAPK/NF-κB signaling pathways in LPS-activated BV-2 microglia

Qin, S., Yang, C., Huang, W., Du, S., Mai, H., Xiao, J., & Lü, T. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.014 · Cited by 119 · see citing works

Protective effects of flavonoids against Alzheimer’s disease-related neural dysfunctions

Bakhtiari, M., Panahi, Y., Ameli, J., & Darvishi, B. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.010 · Cited by 102 · see citing works

Revisiting the neuroinflammation hypothesis in Alzheimer’s disease: a focus on the druggability of current targets

Wong-Guerra, M., Calfío, C., Maccioni, R. B., & Rojo, L. E. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1161850 · Cited by 92 · see citing works

The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development

Baldacci, F., Lista, S., Palermo, G., Giorgi, F. S., Vergallo, A., & Hampel, H. J. (2019) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1628643 · Cited by 66 · see citing works

Shared mechanisms among neurodegenerative diseases: from genetic factors to gene networks

Arneson, D. V., Zhang, Y., Yang, X., & Narayanan, M. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0963-3 · Cited by 63 · see citing works

Boosting phagocytosis and anti‐inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease models

Lecca, D., Janda, E., Mulas, G., Diana, A., Martino, C., Angius, F., Spolitu, S., Casu, M. A., Simbula, G., Boi, L., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14214 · Cited by 61 · see citing works

Understanding the role of SOCS signaling in neurodegenerative diseases: Current and emerging concepts

Cianciulli, A., Calvello, R., Porro, C., Trotta, T., & Panaro, M. A. (2017) · Cytokine &amp; Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.07.005 · Cited by 59 · see citing works

The Oral Microbiome and Inflammation in Mild Cognitive Impairment

Yang, I., Arthur, R. A., Zhao, L., Clark, J., Hu, Y., Corwin, E. J., & Lah, J. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111273 · Cited by 56 · see citing works

Inflammation in Lafora Disease: Evolution with Disease Progression in Laforin and Malin Knock-out Mouse Models

López‐González, I., Viana, R., Sanz, P., & Ferrer, I. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9884-4 · Cited by 54 · see citing works

Learning from the Past: A Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer’s Disease

Ceyzériat, K., Zilli, T., Millet, P., Frisoni, G. B., Garibotto, V., & Tournier, B. B. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200304085513 · Cited by 53 · see citing works

Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease

Zheng, T., & Zhang, Z. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105094 · Cited by 53 · see citing works

Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms

Garcia‐Esparcia, P., López‐González, I., Grau‐Rivera, O., Garrido, M. G., Koneti, A., Llorens, F., Zafar, S., Carmona, M., del Rı́o, J. A., Zerr, I., et al. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00089 · Cited by 52 · see citing works

Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer’s Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia

Oikonomidi, A., Tautvydaitė, D., Gholam‐Rezaee, M., Henry, H., Bacher, M., & Popp, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170335 · Cited by 51 · see citing works

Neuroinflammation in l-DOPA-induced dyskinesia: beyond the immune function

Pisanu, A., Boi, L., Mulas, G., Spiga, S., Fenu, S., & Carta, A. R. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1874-4 · Cited by 49 · see citing works

Severe Urban Outdoor Air Pollution and Children’s Structural and Functional Brain Development, From Evidence to Precautionary Strategic Action

D’Angiulli, A. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00095 · Cited by 46 · see citing works

Microglial Activation Is Modulated by Captopril: in Vitro and in Vivo Studies

Asraf, K., Torika, N., Apte, R., & Fleisher-Berkovich, S. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00116 · Cited by 45 · see citing works

Vascular smooth muscle cell dysfunction contribute to neuroinflammation and Tau hyperphosphorylation in Alzheimer disease

Aguilar-Pineda, J. A., Vera-López, K. J., Shrivastava, P., Chávez‐Fumagalli, M. Á., Nieto-Montesinos, R., Alvarez, K. L. F., Goyzueta-Mamani, L. D., Dávila-Del-Carpio, G., Gómez, B., Miller, C. L., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102993 · Cited by 44 · see citing works

Neuroinflammation in the dorsolateral prefrontal cortex in elderly chronic schizophrenia

López‐González, I., Pinacho, R., Vila, È., Escanilla, A., Ferrer, I., & Ramos, B. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.12.011 · Cited by 43 · see citing works

Targeted genetic analysis of cerebral blood flow imaging phenotypes implicates the INPP5D gene

Yao, X., Risacher, S. L., Nho, K., Saykin, A. J., Wang, Z., & Shen, L. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.06.003 · Cited by 40 · see citing works

Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders

Jung, Y. J., Tweedie, D., Scerba, M. T., Kim, D. S., Palmas, M. F., Pisanu, A., Carta, A. R., & Greig, N. H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.656921 · Cited by 36 · see citing works

Inflammation and regulatory T cell genes are differentially expressed in peripheral blood mononuclear cells of Parkinson’s disease patients

Karaaslan, Z., Kahraman, Ö. T., Şanlı, E., Ergen, H. A., Ulusoy, C. A., Bılgıç, B., Yılmaz, V., Tüzün, E., Hanağası, H. A., & Küçükali, C. İ. (2021) · Scientific Reports · doi:10.1038/s41598-021-81961-7 · Cited by 34 · see citing works

Anti-Inflammatory Phenolic Acid Esters from the Roots and Rhizomes of Notopterygium incisium and Their Permeability in the Human Caco-2 Monolayer Cell Model

Wu, X., Wei, W., Yang, X., Zhang, Y.-B., Xu, W., Yang, Y., Zhong, G., Liu, H., & Yang, S. (2017) · Molecules · doi:10.3390/molecules22060935 · Cited by 32 · see citing works

The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications

Kuter, K. Z., Cenci, M. A., & Carta, A. R. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.02.004 · Cited by 30 · see citing works

Cerebrospinal fluid and blood profiles of transfer RNA fragments show age, sex, and Parkinson's disease‐related changes

Paldor, I., Madrer, N., Vaknine, S., Shulman, D., Greenberg, D., & Soreq, H. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15723 · Cited by 29 · see citing works

Hippocampal neurophysiology is modified by a disease-associated C-terminal fragment of tau protein

Tamagnini, F., Walsh, D. A., Brown, J. T., Bondulich, M. K., Hanger, D. P., & Randall, A. D. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.07.005 · Cited by 28 · see citing works

Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimers Disease

Nagae, T., & Araki, K. (2016) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000441 · Cited by 28 · see citing works

Increased prefrontal cortex interleukin-2 protein levels and shift in the peripheral T cell population in progressive supranuclear palsy patients

Rydbirk, R., Elfving, B., Folke, J., Pakkenberg, B., Winge, K., Brudek, T., & Aznar, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-44234-y · Cited by 27 · see citing works

Let’s make microglia great again in neurodegenerative disorders

Guillot‐Sestier, M., & Town, T. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1792-x · Cited by 26 · see citing works

Butein protects the nonalcoholic fatty liver through mitochondrial reactive oxygen species attenuation in rats

Alshammari, G. M., Balakrishnan, A., & Chinnasamy, T. (2018) · BioFactors · doi:10.1002/biof.1428 · Cited by 26 · see citing works

Sex-Specific Transcriptome Differences in Substantia Nigra Tissue: A Meta-Analysis of Parkinson’s Disease Data

Mariani, E., Lombardini, L., Facchin, F., Pizzetti, F., Frabetti, F., Tarozzi, A., & Casadei, R. (2018) · Genes · doi:10.3390/genes9060275 · Cited by 25 · see citing works

Stem Cell-derived Extracellular Vesicles: A Promising Nano Delivery Platform to the Brain?

Guo, Y., Hu, D., Lian, L., Zhao, L., Li, M., Bao, H., & Xu, S. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10455-4 · Cited by 25 · see citing works

Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease

Bartoletti‐Stella, A., Corrado, P., Mometto, N., Baiardi, S., Durrenberger, P. F., Arzberger, T., Reynolds, R., Kretzschmar, H. A., Capellari, S., & Parchi, P. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1421-1 · Cited by 24 · see citing works

Drosophila melanogaster as a model to understand the mechanisms of infection mediated neuroinflammation in neurodegenerative diseases

Nayak, N., & Mishra, M. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2102066 · Cited by 19 · see citing works

Emerging Potential of Exosomal Non-coding RNA in Parkinson’s Disease: A Review

Zhang, P., Rasheed, M., Liang, J., Wang, C., Feng, L. P., & Chen, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.819836 · Cited by 19 · see citing works

Microglia‐Related Gene Triggering Receptor Expressed in Myeloid Cells 2 (<i>TREM2</i>) Is Upregulated in the Substantia Nigra of Progressive Supranuclear Palsy

Sánchez‐Ruiz de Gordoa, J., Erro, M. E., Vicuña‐Urriza, J., Zelaya, M. V., Tellechea, P., Acha, B., Zueco, S., Urdánoz‐Casado, A., Roldán, M., Blanco‐Luquin, I., et al. (2020) · Movement Disorders · doi:10.1002/mds.27992 · Cited by 18 · see citing works

Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease

Palmas, M. F., Ena, A., Burgaletto, C., Casu, M. A., Cantarella, G., Carboni, E., Etzi, M., Simone, A. D., Fusco, G., Cardia, M. C., et al. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01182-2 · Cited by 17 · see citing works

Candidate genes for tick resistance in cattle: a systematic review combining post-GWAS analyses with sequencing data

dos Santos, C. G., Sousa, M. F., Vieira, J. I. G., de Morais, L. R., Fernandes, A. A. S., Littiere, T. D. O., Otto, P. I., Machado, M. A., da Silva, M. V. G. B., Bonafé, C. M., et al. (2022) · Journal of Applied Animal Research · doi:10.1080/09712119.2022.2096035 · Cited by 16 · see citing works

Inflammation and olfactory loss are associated with at least 139 medical conditions

Leon, M., Troscianko, E. T., & Woo, C. C. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1455418 · Cited by 16 · see citing works

Comparative Analysis of Multiple Neurodegenerative Diseases Based on Advanced Epigenetic Aging Brain

Shi, F., He, Y., Chen, Y., Yin, X., Sha, X., & Wang, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.657636 · Cited by 15 · see citing works

Data-driven biomarker analysis using computational omics approaches to assess neurodegenerative disease progression

Krokidis, M. G., Exarchos, T. P., & Vlamos, P. (2021) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2021094 · Cited by 14 · see citing works

Natural Phytoestrogens

Morissette, M., Litim, N., & Paolo, T. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809593-5.00002-1 · Cited by 14 · see citing works

The Analysis of Blood Inflammation Markers as Prognostic Factors in Parkinson’s Disease

Stanca, D. I., Criciotoiu, O., Neamţu, S.-D., Vasile, R.-C., Berceanu-Bora, N.-M., Minca, T.-N., Pirici, I., Roşu, G. C., & Bondari, S. (2022) · Healthcare · doi:10.3390/healthcare10122578 · Cited by 14 · see citing works

Regional Differences in Neuroinflammation-Associated Gene Expression in the Brain of Sporadic Creutzfeldt–Jakob Disease Patients

Areškevičiūtė, A., Litman, T., Broholm, H., Melchior, L. C., Nielsen, P. R., Green, A., Eriksen, J. O., Smith, C., & Lund, E. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010140 · Cited by 13 · see citing works

Aptamer-enhanced organic electrochemical transistors for ultra-sensitive dopamine detection

Soliman, I., & Gunathilake, C. A. (2024) · Next Materials · doi:10.1016/j.nxmate.2024.100160 · Cited by 12 · see citing works

Variety and Duration of Different Sedentary Behaviors, Inflammation, Genetic Susceptibility, and New-Onset Dementia in the Older Population

Yang, S., Ye, Z., Liu, M., Zhang, Y., Gan, X., Wu, Q., Zhou, C., He, P., Zhang, Y., & Qin, X. (2023) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2023.06.003 · Cited by 12 · see citing works

Secondary Bioactive Metabolites from Foods of Plant Origin as Theravention Agents against Neurodegenerative Disorders

Gomes, T. M., Sousa, P., Campos, C., Perestrelo, R., & Câmara, J. S. (2024) · Foods · doi:10.3390/foods13142289 · Cited by 11 · see citing works

Spatial heterogeneity in microglia‐complement crosstalk: Implications for synaptic pruning in Alzheimer's disease

Ye, Q., Gao, W., Feng, J., Li, X., Li, J., Yang, F., Li, L., Zi, M., Wu, X., Gao, H., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71185 · Cited by 11 · see citing works

Polygenic mediation analysis of Alzheimer's disease implicated intermediate amyloid imaging phenotypes.

Yingxuan, E., Yao, X., Liu, K., Risacher, S. L., Saykin, A. J., Long, Q., Zhao, Y., & Shen, L. (2020) · PubMed Central · Cited by 11 · see citing works

Biological characteristics and transcriptomic profile of adipose-derived mesenchymal stem cells isolated from prion-infected murine model

Zayed, M., Kim, Y., & Jeong, B. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04273-x · Cited by 10 · see citing works

Epigenetic and transcriptomic characterization of maternal-fetal interface in patients with recurrent miscarriage via an integrated multi-omics approach

Wang, L., Deng, Z., Yang, J., Zhao, Y., Zhou, L., Diao, L., Li, L., & Cheng, Y. (2022) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2022.103754 · Cited by 10 · see citing works

Association between SORL1 polymorphisms and the risk of Alzheimer's disease

Cong, L., Kong, X., Wang, J., Du, J., Xu, Z., Xu, Y., & Zhao, Q. S. (2018) · Journal of Integrative Neuroscience · doi:10.31083/jin-170051 · Cited by 10 · see citing works

Regional Gene Expression of Inflammation and Oxidative Stress Responses Does Not Predict Neurodegeneration in Aging

López‐González, I., Cordomí, C. T., & Ferrer, I. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw117 · Cited by 10 · see citing works

Correlation between CAT polymorphism and susceptibility to DMAc-induced abnormal liver function: a case-control study of Chinese population

Song, X., Gong, W., Shen, H., Li, X., Ding, L., Han, L., Zhang, H., Zhu, B., & Liu, X. (2017) · Biomarkers · doi:10.1080/1354750x.2017.1360942 · Cited by 10 · see citing works

Association between SORL1 polymorphisms and the risk of Alzheimer’s disease

Cong, L., Kong, X., Wang, J., Du, J., Xu, Z., Xu, Y., & Zhao, Q. S. (2017) · Journal of Integrative Neuroscience · doi:10.3233/jin-170051 · Cited by 9 · see citing works

Patients with obstructive sleep apnea have suppressed levels of soluble cytokine receptors involved in neurodegenerative disease, but normal levels with airways therapy

Wang, Y., Meagher, R. B., Ambati, S., Ma, P., & Phillips, B. G. (2020) · Sleep And Breathing · doi:10.1007/s11325-020-02205-y · Cited by 9 · see citing works

Genetic analysis of potential biomarkers and therapeutic targets in neuroinflammation from sporadic Creutzfeldt–Jakob disease

Cheng, Y., Chen, T., & Hu, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-41066-9 · Cited by 8 · see citing works

Physiology and Pathology of Aging

Hirsch, C. H., & Hategan, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-67555-8_1 · Cited by 8 · see citing works

Disulfidoptosis as a Novel Mechanism of Neuronal Death: Insights from Creutzfeldt-Jakob Disease

Wu, Q., Liu, S.-P., Liu, C., Chen, X. S., Zhou, H., & Zhao, H. (2024) · World Neurosurgery · doi:10.1016/j.wneu.2024.08.070 · Cited by 7 · see citing works

Transcriptome and Translatome Regulation of Pathogenesis in Alzheimer’s Disease Model Mice

Eastman, G., Sharlow, E. R., Lazo, J. S., Bloom, G. S., & Sotelo-Silveira, J. R. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215357 · Cited by 7 · see citing works

Inflammation in Alzheimer's Disease, and Prevention with Antioxidants and Phenolic Compounds – What Are the Most Promising Candidates?

Sharman, M. J., Verdile, G., Kirubakaran, S., & Münch, G. W. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch8 · Cited by 7 · see citing works

Therapeutic Potential of Sea Cucumber-Derived Bioactives in the Prevention and Management of Brain-Related Disorders: A Comprehensive Review

Debi, P. R., Barua, H., Ahmmed, M. K., & Bhowmik, S. (2025) · Marine Drugs · doi:10.3390/md23080310 · Cited by 6 · see citing works

Genomic, transcriptomic and RNA editing analysis of human MM1 and VV2 sporadic Creutzfeldt-Jakob disease

Tarozzi, M. E., Baiardi, S., Sala, C., Bartoletti‐Stella, A., Parchi, P., Capellari, S., & Castellani, G. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01483-9 · Cited by 6 · see citing works

Bayesian Cox Proportional Hazards Model in Survival Analysis of HACE1 Gene with Age at Onset of Alzheimer's Disease

Wang, K., Liu, Y., Shaoqing, G., Xu, C. D., Xie, X., Wang, L., & Xingguang, L. (2017) · International Journal of Clinical Biostatistics and Biometrics · doi:10.23937/2469-5831/1510014 · Cited by 6 · see citing works

The role of neuroinflammation in developmental neurotoxicity, tackling complexity in children's exposures and outcomes

D’Angiulli, A. (2018) · Advances in neurotoxicology · doi:10.1016/bs.ant.2018.10.008 · Cited by 6 · see citing works

The Genetic Background of the Immunological and Inflammatory Aspects of Progressive Supranuclear Palsy

Alster, P., & Madetko‐Alster, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26093927 · Cited by 5 · see citing works

Genetic causal relationship between multiple immune cell phenotypes and Parkinson’s disease: a two-sample bidirectional Mendelian randomization study

Chen, H., Xie, W., Chang, Z., Zhang, J., & Xie, D. (2024) · Journal of Neurophysiology · doi:10.1152/jn.00481.2023 · Cited by 5 · see citing works

The possible connection between neutrophil-to-high-density lipoprotein ratio and cerebral perfusion in clinically established corticobasal syndrome: a pilot study

Chunowski, P., Migda, B., Madetko‐Alster, N., Migda, A. M., Kutyłowski, M., Królicki, L., & Alster, P. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1464524 · Cited by 5 · see citing works

Therapeutic options for Progressive Supranuclear Palsy including investigational drugs

Shoeibi, A., & Litvan, I. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2017.1335596 · Cited by 5 · see citing works

Potential Role of Aminoprocalcitonin in the Pathogenesis of Alzheimer Disease

Tavares, E., Antequera, D., López‐González, I., Ferrer, I., Miñano, F. J., & Carro, E. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.06.006 · Cited by 5 · see citing works

Physiology and Pathology of Aging

Hirsch, C. H., & Hategan, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-47802-4_1 · Cited by 5 · see citing works

CD33 polymorphisms and Parkinson’s disease Parkinson’s disease in northern Chinese Han population: A case-control study

Tian, Q., Sun, X., Li, C., Yang, Y., Hou, B., & Xie, A. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137400 · Cited by 4 · see citing works

Inhibition of β-amyloid Aggregation of Ugni molinae Extracts

Jara-Moreno, D., Riveros, A. L., Barriga, A., Kogan, M. J., & Delporte, C. L. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200113160840 · Cited by 4 · see citing works

Spilling the T: T cells in tauopathy mechanisms, disease progression, and therapeutic horizons

Bosch, M. E., & Ulrich, J. D. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00020-5 · Cited by 3 · see citing works

Оn the relationship of neurodergenerative diseases with air pollution by particulate matter

Колпакова, А. Ф., Sharipov, R., & Volkova, O. A. (2022) · Russian neurological Journal · doi:10.30629/2658-7947-2022-27-4-5-15 · Cited by 2 · see citing works

Neuroinflammation in Alzheimer’s and Parkinson’s diseases: pathogenic mechanisms and therapeutic strategies

Wang, Q.-Q., Sun, Q.-Q., Guo, Y.-S., Yin, S., & Zhou, J. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00571-3 · Cited by 2 · see citing works

A “keto-enol” plaque buster mechanism to diminish Alzheimer’s β-Amyloid burden

Oláh, Z., Pecze, L., Kocsis, É., & Viskolcz, B. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.07.086 · Cited by 2 · see citing works

Deficits in or Preservation of Basic Number Processing in Parkinson's Disease? A Registered Report

Loenneker, H. D., Artemenko, C., Willmes, K., Liepelt‐Scarfone, I., & Nuerk, H. (2024) · Journal of Neuroscience Research · doi:10.1002/jnr.25397 · Cited by 1 · see citing works

Deficits in or preservation of basic number processing in Parkinson’s disease? A registered report

Loenneker, H. D., Artemenko, C., Willmes, K., Liepelt‐Scarfone, I., & Nuerk, H. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24907 · Cited by 1 · see citing works

Gene Expression Profiling and Bioinformatics Analysis in Neurodegenerative Diseases

Krokidis, M. G., Exarchos, T. P., & Vlamos, P. (2021) · Springer eBooks · doi:10.1007/978-3-319-75479-6_57-1 · Cited by 1 · see citing works

Gene Expression Profiling and Bioinformatics Analysis in Neurodegenerative Diseases

Krokidis, M. G., Exarchos, T. P., & Vlamos, P. (2023) · Springer eBooks · doi:10.1007/978-3-319-75922-7_57 · Cited by 1 · see citing works

Physiology and Pathology of Aging

Hategan, A., Bourgeois, J. A., Cheng, T. Z., & Young, J. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-77128-1_1

Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analysesPreprint

Vastrad, B. M., Vastrad, C. M., & Kotturshetti, I. (2020) · medRxiv · doi:10.1101/2020.12.21.20248688

Association of SCN2A single nucleotide polymorphisms with Parkinson’s disease: evidence from a case-control study

Li, T., Wang, J., Gao, G., Tao, B., Yu, Q., Huang, S., Zhang, Y., & Zhang, P. (2025) · International Journal of Neuroscience · doi:10.1080/00207454.2025.2501651

Additional file 1 of Genomic, transcriptomic and RNA editing analysis of human MM1 and VV2 sporadic Creutzfeldt-Jakob disease

Tarozzi, M. E., Baiardi, S., Sala, C., Bartoletti‐Stella, A., Parchi, P., Capellari, S., & Castellani, G. (2024) · Figshare · doi:10.6084/m9.figshare.26554430

Design, synthesis and characterization of protein-protein interaction disruptors related to early amyloidogenic phenomena in Alzheimer's disease

Giovannini, J. (2021) · theses.fr (ABES) · doi:10.70675/fb583cbdzb4cez4d61zbb7dz9ee01b9f6086

Role of T-cell immunity in the pathophysiology of Alzheimer’s disease and other Tauopathies

Matta, K. (2024) · theses.fr (ABES) · doi:10.70675/cea4fe5ez67c3z4445z92f7z39af62ba059b

Inflammation in Neurodegenerative Disorders: Friend or Foe?

Galimberti, D., Fenoglio, C., & Scarpini, E. A. (2008) · Current Aging Science · doi:10.2174/1874609810801010030 · Cited by 41 · see citing works

Inflamación del sistema nervioso central en enfermos neurodegenerativas humanas con agregados de proteinas y poliglucosanos anormales y en modelos animales

González, I. L. (2016) · Dialnet (Universidad de la Rioja)

Neuroinflammatory Signals in Alzheimer Disease and APP/PS1 Transgenic Mice

López‐González, I., Schlüter, A., Aso, E., Garcia‐Esparcia, P., Ansoleaga, B., Llorens, F., Carmona, M., Moreno, J. R., Fuso, A., Portero‐Otín, M., et al. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000176 · Cited by 125 · see citing works

Inflammation and Brain Structure in Alzheimer’s Disease and Other Neurodegenerative Disorders: a Mendelian Randomization Study

Liu, W., Zhang, Y.-R., Ge, Y., Wang, H.-F., Cheng, W., & Yu, J. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03648-6 · Cited by 18 · see citing works

Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines

Tanaka, M., Toldi, J., & Vécsei, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072431 · Cited by 225 · see citing works